Advertisement

Metoclopramide and Tardive Dyskinesia

      This paper is only available as a PDF. To read, Please Download here.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • American Psychiatric Association
        Diagnostic and Statistical Manual of Mental Disorders. American Psychiatric Press, Washington, DC1987 (3rd ed. rev.)
        • Folstein M.F.
        • Folstein S.E.
        • McHugh P.R.
        Mini-Mental State: A practical method for grading the cognitive state of patients for the clinician.
        J Psychiatr, Res. 1975; 12: 189-198
        • Ganzini L.
        • Heintz R.T.
        • Hoffman W.F.
        • Casey D.E.
        The prevalence of tardive dyskinesia in neuroleptic-treated diabetics: A controlled study.
        Arch Gen Psychiatry. 1991; 48: 259-263
        • Ganzini L.
        • Casey D.E.
        • Hoffman W.F.
        • McCall A.L.
        The prevalence of metoclopramide-induced Tardive Dyskinesia and Acute extrapyramidal movement disorders.
        Arch Intern Med. 1993; 153: 1469-1475
        • Jeste D.V.
        • Caligiuri M.P.
        Tardive dyskinesia.
        Schizophr Bull. 1993; 19: 303-315
        • Jeste D.V.
        • Wyatt R.J.
        Understanding and Treating Tardive Dyskinesia.
        Guilford Press, New York1982
        • Kebabian J.W.
        • Calne D.B.
        Multiple receptors for dopamine.
        Nature. 1979; 277: 93-96
        • National Institute of Mental Health
        Abnormal Involuntary Movement Scale (AIMS).
        Early Clin Drug Eval Unit Intercom. 1975; 4: 3-6
        • Owens D.G.
        • Johnstone E.C.
        • Frith C.D.
        Spontaneous involuntary disorders of movement.
        Arch Gen Psychiatry. 1982; 39: 452-461
        • Physicians' Desk Reference
        Physicians' Desk Reference (PDR).
        Medical Economics Data, Montvale, NJ1993
        • Schooler N.R.
        • Kane J.M.
        Research diagnoses for tardive dyskinesia.
        Arch Gen Psychiatry. 1982; 39: 486-487
        • Sewell D.D.
        • Jeste D.V.
        Metoclopramide-associated tardive dyskinesia: An analysis of 67 cases.
        Arch Family Med. 1992; 1: 271-278
        • Sewell D.D.
        • Yoshinobu B.H.
        • Caligiuri M.P.
        • Jeste D.V.
        Metoclopramide-associated tardive dyskinesia in hemodialysis patients with diabetes mellitus: Two case reports.
        Gen Hosp Psych. 1992; 14: 416-419
        • Simpson G.M.
        • Angus J.W.
        A rating scale for extrapyramidal side effects.
        Acta Psychiatr Scand. 1970; 45: 11-12
        • Simpson G.M.
        • Lee J.H.
        • Zoubok B.
        • Gardos G.
        A rating scale for tardive dyskinesia.
        Psychopharmacol (Berl). 1979; 64: 171-179
        • Woerner M.G.
        • Saltz B.L.
        • Kane J.M.
        • Lieberman J.A.
        • Alvir M.J.
        Diabetes and development of tardive dyskinesia.
        Am J Psychiatry. 1993; 150: 966-968
        • Yassa R.
        • Jeste D.V.
        Gender differences in tardive dyskinesia: A critical review of the literature.
        Schizophr Bull. 1992; 18: 701-715